Bill to bring biomanufacturing supply chains back to U.S.

Posted 8/28/26

The bill seeks to address supply-chain gaps that can make it difficult for U.S. biotechnology companies to manufacture products domestically at scale.

This item is available in full to subscribers.

Please log in to continue

Log in